Q4 2026 Anupam Rasayan India Ltd Earnings Call Transcript
Key Points
- Anupam Rasayan India Ltd (BOM:543275) delivered its highest ever revenue in FY26, showcasing strong execution across key business verticals.
- The company reported a significant increase in operating cash flow to INR334 crores, driven by improved operational efficiency and better working capital management.
- Revenue from High Performance Materials increased threefold, and Pharma revenue grew tenfold, indicating successful diversification and expansion.
- The acquisition of Jayhawk Fine Chemicals provides a strategic manufacturing footprint in the U.S., enhancing customer capabilities and access to regulated markets.
- The company has entered into a definitive agreement to acquire a significant stake in Bliss GVS Pharma, strengthening its pharmaceutical platform and expanding its value chain.
- EBITDA margin for Q4 FY26 decreased to 22% from 23% in the previous year, indicating pressure on profitability.
- Profit after tax for Q4 FY26 was INR56 crores, down from INR63 crores in Q4 FY25, reflecting a decline in profit margins.
- The company has a significant debt level, with a gross debt of around INR1,500 crores, which could impact financial flexibility.
- The integration of recent acquisitions like Jayhawk and Bliss GVS Pharma may pose challenges and require time to realize full synergies.
- The company's dependence on the Agro Chemicals segment remains high, contributing 55% of revenue, which could be a risk if market conditions change.
Ladies and gentlemen, good day, and welcome to the Anupam Rasayan India Limited Q4 FY26 Earnings Conference Call. (Operator Instructions). Please note that this conference is being recorded.
From the management side, we have with us Mr. Anand Desai, Managing Director; Mr. Gopal Agrawal, Chief Executive Officer; Mr. Amit Khurana, Chief Financial Officer; and Mr. Vishal Thakkar, Deputy Chief Financial Officer.
I now hand the conference over to Mr. Anand Desai. Thank you, and over to you, sir.
Thank you. Good morning, everyone and thank you for joining us for our Q4 and FY26 earnings call. FY26 has been a landmark year for Anupam Rasayan as we delivered our highest ever revenue. I would like to say so thank our customers, employees, shareholders and all stakeholders for their continued trust and support.
We continue to strengthen our position as a globally integrated specialty chemicals company. Our performance in the year was a result of strong execution across key business verticals, improving contribution
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
